Pharmalys Ltd

29/04/2026

Proteins exist in multiple forms called proteoforms, generated from a single gene through sequence variants, alternative splicing, and post-translational modifications. These forms influence protein function, cellular behaviour, and disease outcomes. Advanced proteomics techniques allow researchers to identify and study proteoforms with high precision. Clinically, proteoform diversity affects cancer treatment, neurodegenerative disease progression, and biomarker accuracy. Despite challenges in detecting low-abundance or highly modified variants, integrating proteomics with genomics and AI is advancing precision medicine.

Proteoforms, the diverse molecular variants of proteins, are key to understanding cellular functions, disease mechanisms, and biomarker discovery in proteomics.

27/04/2026

An interesting BBC Sounds episode regarding the declining number of vaccination coverage for measles in the UK, and the issue of the three C’s of vaccine hesitancy: convenience, complacency, and confidence.

James visits Hackney, which has one of the lowest vaccination rates in the country.

25/04/2026

On World Malaria Day, we recognise the global effort to end a disease that still affects millions worldwide. At Pharmalys, we remain committed to advancing clinical research that supports innovation in prevention, treatment, and global health equity.

24/04/2026

As global clinical research evolves, is becoming an essential frontier for innovation and impact. At Pharmalys, our experience across the continent shows that success requires more than technical expertise, it demands resilience, adaptability, and strong local insight.

By combining global standards with on-site experience, our teams navigate complex environments, support site development, and deliver high quality clinical trials.

Read the full article here https://www.pharmalys.com/delivering-excellence-under-complexity-lessons-learned-from-africa/

Pharmalys is an international Clinical Research Organisation (CRO) with a diverse team distributed across Europe, Asia, North America and Africa. Within our global portfolio, we support the ex*****on of numerous clinical trials (CTs) in Africa. Across these projects, the experience, flexibility and....

22/04/2026

In Douala, Cameroon, a new initiative is transforming how public markets operate to make food safer for everyone. Through the “Healthy Food Market” project, launched in partnership with Senegal and supported by the World Health Organization, pilot markets in New Deido and Ndogpassi are adopting improved hygiene, sanitation and food safety practices.

By combining stronger local governance, trader engagement and targeted investments, the project aims to reduce foodborne diseases and set a model for cleaner, safer markets across the city.

Douala —Along with Senegal, Cameroon is implementing the “Healthy Food Market” project in the city of Douala through two pilot markets: New Deido and Ndogpassi. Coordinated by the urban municipality, this project aims to strengthen the prevention of foodborne diseases and improve hygiene, sani...

20/04/2026

On 29 January 2026, WHO and the Delft Digital Ethics Centre convened over 30 international experts to address responsible AI for mental health, highlighting risks from untested generative AI tools, especially among youth. The workshop recommended recognising AI use as a public mental health issue, integrating mental health into AI impact assessments, and co-designing AI tools with experts and people with lived experience.

On 29 January 2026, WHO‑supported experts met at a TU Delft workshop to address the rapid, largely untested use of generative AI for mental health support. Participants warned of risks to well‑being, especially for young people, and called for stronger governance.

17/04/2026

are increasingly recognised as a growing public health concern, with evidence of widespread human exposure through air, food, and water. As research evolves, scientists are beginning to uncover how these particles may impact the human body, raising important questions about long-term health risks and the need for further investigation.

Microplastics are emerging as a major public health concern. Learn how exposure occurs, potential health risks, and what science says about their impact on humans.

15/04/2026

South Sudan’s sustained response has drastically reduced new cases and saved tens of thousands of lives since the outbreak in 2024. Rapid response teams, expanded treatment centres, strengthened surveillance and large-scale campaigns have helped contain the outbreak and protect vulnerable communities.

Juba—South Sudan’s sustained cholera outbreak response has reduced new cases and prevented around 94 000 deaths since the confirmation of the outbreak more than two years ago in September 2024.

13/04/2026

affect differently in women with stress disorders. A study of 31,824 women found lower risk of (Major Adverse Cardiac Events) for most, but not for those with (Post Traumatic Stress Disorder), while women with anxiety or depression still benefited. Findings suggest mental health should guide contraceptive choice and heart health, with future research on blood pressure, clotting markers, and long-term CVD outcomes.

Antonia Seligowski, PhD, of the Neurocardiac Effects of Stress & Trauma Laboratory within the Department of Psychiatry at Mass General Brigham, is the senior author of a paper published in JAMA Network Open, "Hormonal contraceptive use, stress disorders, and cardiovascular and thrombotic risk in wom...

11/04/2026

On World Parkinson’s Day 2026, we stand in support of the millions of people worldwide living with Parkinson’s disease.

This day is an opportunity to raise awareness of a complex and progressive neurological condition that affects not only movement, but also mental health, wellbeing, and quality of life. With over 10 million people impacted globally, and numbers continuing to rise, the need for research, understanding, and improved care has never been greater.

At Pharmalys, we recognise the importance of advancing scientific knowledge, supporting innovation in treatment, and amplifying the voices of those living with Parkinson’s. Every experience is unique, and every story matters.

Let’s challenge misconceptions, promote awareness, and support a future with better care and, ultimately, a cure.

10/04/2026

Pharmalys recently completed a GCLP surveillance audit at Proteome Sciences plc R&D in Frankfurt, reaffirming the laboratory’s continued compliance with high quality clinical laboratory standards and its strong commitment to excellence in regulated research.

Read the full article here

Another successful GCLP audit of Proteome Sciences in Germany completed by Pharmalys, supporting global GCLP accreditation standards.

08/04/2026

Senegal’s decision to join a $12.6 billion U.S.-backed global health initiative marks a significant step in strengthening healthcare systems across Africa. With a focus on long-term investment, system resilience, and expanded access to essential services, this partnership reflects growing momentum towards sustainable healthcare development on the continent.

Senegal joins a $12.6B US-backed global health initiative to strengthen healthcare systems, expand access, and drive long-term health investment across Africa.